About
Alzheimer's Treatments and Diagnostics
Areas of Focus
Categories
DiagnosticsBiologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyChina
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
460
By Phase
PHASE1: 1PHASE2: 1PHASE3: 1
By Status
UNKNOWN: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05344989Lead Sponsor
A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants
PHASE1Unknown
40 participants
Started: May 6, 2022 · Completed: Jul 31, 2024
NCT04141150Lead Sponsor
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
PHASE2Unknown
130 participants
Started: Mar 22, 2022 · Completed: Feb 28, 2025
NCT05542953Lead Sponsor
[18F]APN-1607 PET in Subjects With AD Compared to HC
PHASE3Completed
230 participants
Started: Jan 21, 2022 · Completed: Dec 25, 2023
NCT05326009Collaborator
A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
N/AUnknown
60 participants
Started: Nov 20, 2021 · Completed: May 31, 2023
Locations (1)
Headquarters
Hong Kong, China
Map
Loading map...